pr-10549-preview.bioprocessintl.com Open in urlscan Pro
172.64.144.102  Public Scan

Form analysis
0 forms found in the DOM

Text Content

BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT
This site is operated by a business or businesses owned by Informa PLC and all
copyright resides with them. Informa PLC's registered office is 5 Howick Place,
London SW1P 1WG. Registered in England and Wales. Number 8860726.

BPI EventsAboutSubscribeContribute

Subscribe

Subscribe
REGISTERSign in

Upstream

RELATED TOPICS

 * Bioreactors
 * Biochemicals/Raw Materials
 * Cell Culture Media

 * Expression Platforms
 * Microbial Cell Culture
 * Perfusion Cell Culture

RECENT IN UPSTREAM

See all
Croda Pharma Ask the Expert
Sponsored Content
Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture
with Exceptional Batch-to-Batch ConsistencyIntroducing Super Refined™ Poloxamer
188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch
Consistency
byBPI Contributor
Oct 29, 2024
1 Hr View
Sartorius
Sponsored Content
Building Reliability Into Scale-Up: Targeted Optimization for AAV
ProductionBuilding Reliability Into Scale-Up: Targeted Optimization for AAV
Production
byBPI Contributor
Sep 17, 2024
40 Min View
Downstream

RELATED TOPICS

 * Chromatography
 * Filtration

 * Separation/Purification
 * Viral Clearance

RECENT IN DOWNSTREAM

See all
Saint Gobain Life Sciences filtration
Sponsored Content
Filter Integrity Uncovered: Techniques and Best PracticesFilter Integrity
Uncovered: Techniques and Best Practices
byBPI Contributor
Dec 3, 2024
30 Min View
Bio-Rad Ask the Expert webcast
Sponsored Content
Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic
Process ChallengesEvaluation of a New Multimodal Anion Exchange Resin for
Emerging Biotherapeutic Process Challenges
byBPI Contributor
Nov 14, 2024
15 Min View
Manufacturing

RELATED TOPICS

 * Biosimilars
 * Continuous Bioprocessing
 * Facility Design/Engineering
 * Formulation
 * Single Use
 * Fill/Finish

 * Information Technology
 * Process Monitoring and Controls
 * Supply Chain
 * Validation
 * CMC Forums

RECENT IN MANUFACTURING

See all
908 Devices Ask the Expert
Sponsored Content
Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of
Dynamic Glucose Level Control in CHO Process Improves Product QualityLinking mAb
Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic
Glucose Level Control in CHO Process Improves Product Quality
byBPI Contributor
Nov 19, 2024
30 Min View
Lonza Ask the Expert
Sponsored Content
Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the
TheraPRO® CHO Media SystemIntroduction to Lonza CHO Media Portfolio: Harnessing
Simplicity with the TheraPRO® CHO Media System
byBPI Contributor
Oct 31, 2024
50 Min View
Analytical

RELATED TOPICS

 * QA/QC
 * Cell Line Development
 * PAT
 * Product Characterization

 * Bioanalytical Methods
 * Process Development
 * Assays
 * Laboratory Equipment

RECENT IN ANALYTICAL

See all
ValGenesis Ask the Expert webinar
Sponsored Content
Out of the Box Computer Software Assurance with ValGenesis VLMSOut of the Box
Computer Software Assurance with ValGenesis VLMS
byBPI Contributor
Nov 7, 2024
30 Min View
Samsung S-Tesify
Sponsored Content
Innovative Approaches to Enhance Cell Culture Density for High-Quality
ProductionInnovative Approaches to Enhance Cell Culture Density for High-Quality
Production
byBPI Contributor
Sep 19, 2024
15 Min View
Business

RELATED TOPICS

 * Bioregions
 * Careers & Training
 * Contract Services
 * Economics

 * Pre-Clinical & Clinical Trials
 * Risk Management
 * Intellectual Property
 * Regulatory Affairs

RECENT IN BUSINESS

See all
Scorpius BioManufacturing Ask the Expert webcast
Sponsored Content
An Innovative Funding Model for Biotech CompaniesAn Innovative Funding Model for
Biotech Companies
byBPI Contributor
Dec 10, 2024
7 Min View
Lonza Ask the Expert webcast
Sponsored Content
Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs,
Process Development, and Manufacturing to Ensure Drug QualityNavigating
Biopharma Commercialization: The Interplay of Regulatory Affairs, Process
Development, and Manufacturing to Ensure Drug Quality
byBPI Contributor
Nov 21, 2024
30 Min View
Therapeutic Modalities

RELATED TOPICS

 * Cell Therapies
 * Emerging Therapeutics
 * Gene Therapies
 * Large Molecule Development

 * MAb
 * Personalized Medicine
 * Vaccines

RECENT IN THERAPEUTIC MODALITIES

See all
Roche ATE webinar
Sponsored Content
Decoding AAV Manufacturing: Navigating Critical Quality Attributes and their
AnalyticsDecoding AAV Manufacturing: Navigating Critical Quality Attributes and
their Analytics
byBPI Contributor
Oct 11, 2024
20 Min View
thumbnail
Bioprocess Insider
Biomanufacturing in space accelerating therapy development on
EarthBiomanufacturing in space accelerating therapy development on Earth
byJosh Abbott
Jul 24, 2024
3 Min Read
BioProcess Insider

RELATED TOPICS

 * Deal-Making
 * Facilities & Capacity
 * Global Markets
 * Regulations

 * Therapeutic Class
 * Upstream & Downstream Processing
 * Webcasts
 * BioProcess Insider Podcasts

RECENT IN BIOPROCESS INSIDER

See all
thumbnail
Facilities & Capacity
Lonza calls time on capsules as mAbs and CGT drive core CDMO strategyLonza calls
time on capsules as mAbs and CGT drive core CDMO strategy
byDan Stanton
Dec 16, 2024
3 Min Read
Sartorius CGT newsletter
Sponsored Content
Setting the Standard in Cell and Gene Therapy: Perspectives on Performance,
Scalability, and Regulatory ComplianceSetting the Standard in Cell and Gene
Therapy: Perspectives on Performance, Scalability, and Regulatory Compliance
byBPI Contributor
Dec 4, 2024
2 Min Read




INSIDER NEWS


SK PHARMTECO SECURES $1.4BN GLP-1 DEAL

Dec 19, 2024


MILLIPORESIGMA TO ACQUIRE NETHERLANDS-BASED ORGANOID PIONEER HUB

Dec 18, 2024


ISRAELI BIOMANUFACTURER SCINAI EXPANDS INTO US WITH CDMO SUBSIDIARY

Dec 18, 2024


CGT CATAPULT AND UCL TO DEVELOP DIGITAL TWIN FOR CAR-T MANUFACTURING

Dec 17, 2024
Read More
people in hazmat suits
Vaccines


THE POWER OF UNIVERSAL VACCINES IN THE FIGHT AGAINST BIOLOGICAL WARFARE


THE POWER OF UNIVERSAL VACCINES IN THE FIGHT AGAINST BIOLOGICAL WARFARE

Sep 1, 2024
bioreactor
Bioreactors
Lessons in Bioreactor Scale-Up: Part 3 — Experimental Determination and
Application of Oxygen Mass- Transfer Rate, Mass-Transfer Coefficient, and
Oxygen-Uptake Rate
Lessons in Bioreactor Scale-Up — Part 3: Experimental Determination and
Application of Oxygen Mass- Transfer Rate, Mass-Transfer Coefficient, and
Oxygen-Uptake Rate

Sep 9, 2024

Continuous Bioprocessing
Controlling Integrated, Continuous Processes: Real-Time Monitoring with
Feed-Back and Feed-Forward Controls Enables Synchronization and Enhances
Robustness
Controlling Integrated, Continuous Processes: Real-Time Monitoring with
Feed-Back and Feed-Forward Controls Enables Synchronization and Enhances
Robustness

Sep 23, 2024




BIOPROCESS INSIDER DAILY - BIOTECH WEEK BOSTON

Read More

Webcasts
Talent dearth continues to puzzle life sciences industry, says recruitment
expert

Andrew Mears, CEO of Lead Candidate, highlighted a dichotomy in the industry,
where some sectors are downsizing while others are experiencing rapid growth
during a video interview at Biotech Week Boston (BWB).

Therapeutic ClassPost-pandemic dip: Panelists discuss CGT challenges

Experts call for better analytics, customization, R&D, and strategic investments
as cell and gene therapies struggle with funding challenges and complex
manufacturing needs.

Facilities & CapacityBIOSECURE: China’s loss could be India’s gain

Aurigene’s chief commercial officer says his firm and other Indian CDMOs are “a
very viable alternative” if major Chinese manufacturers are removed from the US
biopharma supply chain.

Therapeutic ClassHow and why AstraZeneca’s oncology eyes turned to cell
therapies

Cell therapies will play an increasingly important position in AstraZeneca’s
broad oncology pipeline, an SVP told delegates at Biotech Week Boston (BWB) last
month.


LATEST ISSUE

September 2024 Issue

Current Issue



Read Now
Process Monitoring and Control: Data-Powered Operations for Drug Quality

Featured Report



Read Now
Special Report

From Pipettes to Infusion Pumps: Volume Accuracy in Regulated Industries and Its
Critical Impact



Read Now
Archive

Upstream Processing

BPI Theater panelists
Expression Platforms
Improving Expression and Manufacturing of Novel Biologics
Improving Expression and Manufacturing of Novel Biologics

Jul 31, 2024

turbulent flow image
Bioreactors
Lessons in Bioreactor Scale-Up, Part 2: A Refresher on Fluid Flow and Mixing
Lessons in Bioreactor Scale-Up, Part 2: A Refresher on Fluid Flow and Mixing

Jun 12, 2024


Sponsored Content
Empowering Biologic Breakthroughs: Transforming Tomorrow’s Healthcare Landscape
Through Microbial-Based Development and Manufacturing
Empowering Biologic Breakthroughs: Transforming Tomorrow’s Healthcare Landscape
Through Microbial-Based Development and Manufacturing

Mar 28, 2024


View More

Downstream Processing

quantitative venn diagram
Sponsored Content
LC-MS Detection of Host Cell Proteins: Antibody Affinity Extraction Sample
Preparation Outperforms Native Digestion
LC-MS Detection of Host Cell Proteins: Antibody Affinity Extraction Sample
Preparation Outperforms Native Digestion

Jul 29, 2024

Navigating Biotherapeutic Complexity: Tailored Chromatography Resins to Enable
Purification Success
Sponsored Content
Navigating Biotherapeutic Complexity: Tailored Chromatography Resins to Enable
Purification Success
Navigating Biotherapeutic Complexity: Tailored Chromatography Resins to Enable
Purification Success

Jun 12, 2024


Simplifying Downstream Processing: Innovative Solutions for Filtration and
Chromatography Cover
Sponsored Content
Simplifying Downstream Processing: Innovative Solutions for Filtration and
Chromatography
Simplifying Downstream Processing: Innovative Solutions for Filtration and
Chromatography

Jun 12, 2024


View More

Manufacturing

eBook cover
Sponsored Content
eBook: Drug Delivery — New Formats for Novel Biopharmaceuticals
eBook: Drug Delivery — New Formats for Novel Biopharmaceuticals

Jun 26, 2024

buffer design workflow
Information Technology
Buffer Design for Biopharmaceutical Processes: An Online Tool for Designing and
Understanding Buffers
Buffer Design for Biopharmaceutical Processes: An Online Tool for Designing and
Understanding Buffers

Jun 19, 2024


digital globe
Information Technology
Keys to Successful Technology Transfer
Keys to Successful Technology Transfer

Jun 12, 2024


View More

Analytical

Cell Therapies
Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor
Cell Therapies: Part 1 — In-Process and Drug Product Control
Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor
Cell Therapies: Part 1 — In-Process and Drug Product Control
QA/QC
Practical Applications of Process Capability Indices in the Biopharmaceutical
Industry: A Simulation-Based Study
Practical Applications of Process Capability Indices in the Biopharmaceutical
Industry: A Simulation-Based Study

Corrective and preventive actions
QA/QC
Determining Sample Size for Demonstrating Zero Failures: Ensuring the
Effectiveness of Corrective and Preventive Actions
Determining Sample Size for Demonstrating Zero Failures: Ensuring the
Effectiveness of Corrective and Preventive Actions

View More

Business

scientist at computer
Bioregions
US–India Collaborative Innovations for Rapid Drug Discovery
US–India Collaborative Innovations for Rapid Drug Discovery
business man in choppy waters
Economics
Navigating Choppy Waters: Three Resilient Marketing Tactics for Biotechnology
Companies amid Market Turmoil
Navigating Choppy Waters: Three Resilient Marketing Tactics for Biotechnology
Companies amid Market Turmoil

Outsourcing — India's Burgeoning Biologics CDMO Marketplace eBook Cover
Sponsored Content
eBook: Outsourcing — India's Burgeoning Biologics CDMO Marketplace
eBook: Outsourcing — India's Burgeoning Biologics CDMO Marketplace

View More

Therapeutic Modalities

handshake
Cell Therapies
Elevating the CGT Manufacturing Game: How Outsourcing Enables Success
Elevating the CGT Manufacturing Game: How Outsourcing Enables Success
Allogeneic Cell Therapy eBook cover
Sponsored Content
eBook: Allogeneic Cell Therapy — From Clinical Concept to Viable Product
eBook: Allogeneic Cell Therapy — From Clinical Concept to Viable Product

Macroscopic macrophage image
Emerging Therapeutics
A Milestone in Macrophage-Based Cancer Treatment: Leveraging Chimeric Antigen
Receptors To Address Solid Tumors
A Milestone in Macrophage-Based Cancer Treatment: Leveraging Chimeric Antigen
Receptors To Address Solid Tumors

View More


LATEST EBOOKS

See All
Facility Design/EngineeringeBook: Sustainable Facilities — Emerging Approaches
to Design and ConstructioneBook: Sustainable Facilities — Emerging Approaches to
Design and Construction



Cell TherapieseBook: Challenges of Commerical-Scale Autologous CAR-T Cell
ManufacturingeBook: Challenges of Commerical-Scale Autologous CAR-T Cell
Manufacturing



Fill/FinisheBook: Drug Delivery — New Formats for Novel BiopharmaceuticalseBook:
Drug Delivery — New Formats for Novel Biopharmaceuticals





Special Reports


Sponsored Content
Redefining Cell Line Development with a New Automated Clone Screening
SystemRedefining Cell Line Development with a New Automated Clone Screening
System

The Cydem VT system combines multiple trusted Beckman Coulter Life Sciences
technologies into one advanced platform that empowers lab managers with a far
more effective, higher-throughput method for top clone screening in Cell Line
Development—offering increased confidence that promising clones don’t get
overlooked in the process of consistently selecting the best.  Key features:
Register or Login and hit Download Now to get the full Special Report.

Sponsored Content
Considerations for the Journey to CommercializationConsiderations for the
Journey to Commercialization

The journey from preclinical development to commercialization of a new
biopharmaceutical is long and challenging. The entire process requires
persistence, adaptability, and strategic foresight. Only with a well-coordinated
effort across disciplines and business functions can a new biologic drug
successfully advance from laboratory to market. Partnering with a CDMO can be
invaluable in navigating such challenges to provide flexibility, enabling drug
sponsors to focus on their core competencies while relying on their partners to
handle the intricacies of manufacturing and regulatory compliance. Such
partnerships can reduce risks significantly and help ensure that a new biologic
reaches the market as efficiently as possible. Learn key considerations for the
journey to commercialization. Register or Login and hit Download Now to get the
full Special Report.

See all

Ask the Expert Webcasts


Sponsored Content
Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and
Improved ADCC with S-AfuCHO™Advanced CLD with S-CHOice®: Higher Productivity
with Transposase Technology and Improved ADCC with S-AfuCHO™

This webcast features: Janet Lee, director, cell line development, Samsung
Biologics. The increasing complexity of biopharmaceutical molecules is driving
innovation in cell line development (CLD) to enhance productivity and
functionality. To address these evolving demands, Samsung Biologics has
developed two advanced platforms: S-CHOice® and S-AfuCHO™. The S-CHOice®
platform, powered by transposase technology, tackles common CLD challenges such
as low protein expression, multi-chain molecule complexity, and clonal
instability. It ensures efficient and scalable biologics production while
meeting stringent timelines and reducing product impurities. The S-AfuCHO™
platform features an afucosylated CHO cell line engineered through FUT8 knockout
technology. By removing core fucose from the antibody’s Fc region, it enhances
binding affinity to FcγIIIa receptors, significantly improving
antibody-dependent cellular cytotoxicity (ADCC) functionality. Join this webinar
to learn how these platforms optimize CLD pe...

Sponsored Content
An Innovative Funding Model for Biotech CompaniesAn Innovative Funding Model for
Biotech Companies

This webcast features: Joe Payne, president & COO & Jeff Wolf, founder & CEO,
Scorpius BioManufacturing. Too many promising biologic candidates are stalled
without critical early-stage funding. Grant funding often falls short of the
capital needed for pre-clinical and phase 1 manufacturing, but dilutive capital
is hard to secure without positive early-stage data. In this webinar, learn
about a hybrid model for capital-efficient access to cGMP manufacturing, process
development, and analytical services for early-stage biotech companies through
in-kind equity investment. Hear from Scorpius’ president and founder about why
this US biologics CDMO was inspired to develop an innovative funding model to
support innovative biotech companies. Thank you for your interest in this
webcast. You may submit your request to view the webcast, and you will receive a
confirmation email with log-in details.

See all

White Papers

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process
Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process
Development and Scale-Up for CHO-K1 Cells
View More

Posters

Accelerating Cell Line Development with an Efficient, Combined Platform Approach
Sponsored Content
Accelerating Cell Line Development with an Efficient, Combined Platform Approach
Accelerating Cell Line Development with an Efficient, Combined Platform Approach
Evaluation Of a New Glucose Control Strategy Using CITSens Bio APC (Automated
Process Control) for CHO Fed-Batch Application
Sponsored Content
Evaluation Of a New Glucose Control Strategy Using CITSens Bio APC (Automated
Process Control) for CHO Fed-Batch Application
Evaluation Of a New Glucose Control Strategy Using CITSens Bio APC (Automated
Process Control) for CHO Fed-Batch Application


High Productivity and Process Economy in GxP Applications with the Octet™
Platform
Sponsored Content
High Productivity and Process Economy in GxP Applications with the Octet™
Platform
High Productivity and Process Economy in GxP Applications with the Octet™
Platform
View More

Videos

Sponsored Content
Accelerating Process Development Through Rapid Aggregate Screening
Accelerating Process Development Through Rapid Aggregate Screening
View More

BPI CONTENT

BPI ArchiveBioProcess Insider NewsSubscribe to BioProcess Insider Newsletter

RESOURCES

EventsWebinarsWhite PapersPostersVideosPodcasts

ABOUT BPI

Who We AreEditorial AdvisorsAuthor GuidelinesAdvertising/Media KitList
Rental/ReprintsCareers

JOIN US

Subscribe
Subscribe

FOLLOW US



Copyright © 2024 Informa Connect Limited. Registered in England & Wales with
number 01835199, registered office 5 Howick Place, London, SW1P 1WG.

Cookie Policy|Privacy|Terms|CCPA: Do not sell my personal info